NEUTEC
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

NEUTEC Trademark

Serial Number: 90549924

NEUTEC is a trademark filed by NEUTEC ILAC SANAYI TICARET ANONIM SIRKETI on February 26, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

NEUTEC ILAC SANAYI TICARET ANONIM SIRKETI (8 trademarks)

Yildiz Teknik Universitesi, Davutpasa
Esenler, Istanbul 34220 , TR

Entity Type: 03

Trademark Details

Filing Date

February 26, 2021

Registration Date

Not Registered

Published for Opposition

October 26, 2021

Goods & Services

Manufacturing services for others in the field of pharmaceuticals

Pharmaceutical preparations for the treatment and prevention of alimentary tract and metabolic diseases, blood and blood forming organ diseases, cardiovascular system diseases, dermatological diseases, genito-urinary system and sex hormones diseases, systemic hormonal diseases, systemic infectious diseases, neoplastic or immunomodulatory diseases, musculo-skeletal system diseases, nervous system diseases, parasitological diseases, respiratory system diseases, sensory organs diseases

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies

Inhalers for therapeutic use; Instruments and apparatus provided empty used for the inhalation of pharmaceuticals; Medical apparatus for facilitating the inhalation of pharmaceutical preparations

Chemical research services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Inspection of pharmaceuticals for quality control purposes; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 7, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 7, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jun 14, 2024 EX5G
SOU EXTENSION 5 FILED
Jun 14, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2023 EXRA
SOU EXTENSION 4 GRANTED
Dec 7, 2023 EX4G
SOU EXTENSION 4 FILED
Dec 7, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 7, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 23, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jun 21, 2023 EX3G
SOU EXTENSION 3 FILED
Jun 21, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 21, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2022 EXRA
SOU EXTENSION 2 GRANTED
Dec 21, 2022 EX2G
SOU EXTENSION 2 FILED
Dec 21, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 21, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 31, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 31, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 31, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 21, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 26, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 6, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2021 NWOS
NEW APPLICATION ENTERED
Mar 2, 2021 NWAP